MARKET

CPTCF

CPTCF

Cytophage Tech
Grey
--
NaN%
Opening
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Cytophage Technologies reports Q3 results
Seeking Alpha · 11/28/2024 06:16
Cytophage Technologies reports Q2 results
Seeking Alpha · 08/28/2024 18:15
About CPTCF
Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.

Webull offers Cytophage Technologies Ltd stock information, including Grey: CPTCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPTCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPTCF stock methods without spending real money on the virtual paper trading platform.